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Distributional benefits of tobacco tax and  
smoke–free workplaces in China: A modeling 
study
Background Tobacco taxation and smoke–free workplaces reduce 
smoking, tobacco–related premature deaths and associated out–of–
pocket health care expenditures. We examine the distributional 
consequences of a price increase in tobacco products through an 
excise tax hike, and of an implementation of smoke–free workplac-
es, in China.
Methods We use extended cost–effectiveness analysis (ECEA) to 
evaluate, across income quintiles of the male population (the large 
majority of Chinese smokers), the premature deaths averted, the 
change in tax revenues generated, and the financial risk protection 
procured (eg, poverty cases averted, defined as the number of in-
dividuals no longer facing tobacco–related out–of–pocket expen-
ditures for disease treatment, that would otherwise impoverish 
them), that would follow a 75% increase in cigarette prices through 
substantial increments in excise tax fully passed onto consumers, 
and a nationwide total implementation of workplace smoking bans.
Results A 75% increase in cigarette prices would avert about 24 
million premature deaths among the current Chinese male popula-
tion, with a third among the bottom income quintile, increase ad-
ditional tax revenues by US$ 46 billion annually, and prevent 
around 9 million poverty cases, 19% of which among the bottom 
income quintile. Implementation of smoking bans in workplaces 
would avert about 12 million premature deaths, with a fifth among 
the bottom income quintile, decrease tax revenues by US$ 7 billion 
annually, and prevent around 4 million poverty cases, 12% of which 
among the bottom income quintile.
Conclusions Increased excise taxes on tobacco products and work-
place smoking bans can procure large health and economic benefits 
to the Chinese population, especially among the poor.
Electronic supplementary material: 
The online version of this article contains supplementary material.
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China, with its 300 million plus smoking population ie, nearly one–third 
of the world's total, can alleviate much of the global burden of tobacco–
related disease by effectively implementing tobacco control policies. Since 
ratification of the World Health Organization’s (WHO) Framework Con-
vention on Tobacco Control (FCTC) in 2005, China has shown poor 
compliance to the FCTC’s Monitor, Protect, Offer, Warn, Enforce, and 
Raise (MPOWER) measures [1-3]. For example, tobacco taxes remain 
low, contributing only 56% of final cigarette prices, and nationwide smok-
ing bans are yet to be comprehensively implemented [3,4].
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Besides significantly contributing to premature mortality, tobacco use can impose severe financial conse-
quences for households. Out–of–pocket (OOP) health care expenditures associated with the treatment 
of tobacco–related disease can be impoverishing. Cigarette expenditures also form a large proportion of 
all household expenditures for the poor, and together with associated health care expenses arising from 
smoking can contribute to increased poverty rates [5-8].
China’s slow response to smoking can be attributed to a deeply engrained tobacco culture along with 
structural and political obstructions [3]. Nevertheless, public support for tobacco control is growing [9,10] 
indicating potential for scaling up policies such as tobacco tax and smoke–free workplaces. Tobacco tax-
ation is the most effective control policy [11,12], and modeling studies that assumed taxes fully passed 
onto consumers found substantial health and financial gains with the lowest income groups largely ben-
efiting [13-15]. Yet, tobacco taxation has been so far underused in China [3]. Furthermore, the country 
may count up to 740 million individuals exposed to secondhand smoke (SHS) [3], which causes cancers 
and cardiovascular diseases [16]. Though policies against SHS are formulated primarily to protect non–
smokers, they can create smoke–free areas and encourage smokers to quit or smoke less. For instance, a 
meta–analysis showed that workplace smoking bans in four high–income countries led to an average ab-
solute 4% reduction in smoking prevalence [17]. However, the evidence on the effectiveness of smoke–
free policies in reducing smoking in general is mixed, with variable effect sizes [17-19].
In China smoke–free policies have been differentially implemented at municipal and regional levels, and 
prominently enforced only during major events like the Beijing Olympics [20]. Overall, the proportion 
of workplaces having bans could range in 2010 from 60% in Shanghai to 20% in Jiangxi [21], and would 
be higher than the proportion of indoor public places having bans [21]. In 2014, nationwide workplace 
bans were officially proposed and relayed with large media coverage. Encouragingly, the “coming into ef-
fect” of comprehensive bans in Beijing in June 2015 was hailed domestically and internationally [22]. 
Other Chinese cities have adopted smoke–free laws. However, many municipal regulations are not effec-
tive due to weak enforcement including partial bans allowing for example smoking in some public 
places [20].
Using extended cost–effectiveness analysis (ECEA) methods [14,15,23,24], the objective of this paper is 
to examine and compare the distributional impact of expanding two critical tobacco control policies in 
China: aggressive increase in the excise tax on tobacco products; and enforcement of smoking bans in 
workplaces. In doing so, we update a previously validated ECEA framework and analysis [14] that esti-
mated the health benefits, change in tax revenues, and financial risk protection, by socio–economic group, 
in China.
METHODS
We utilize an existing ECEA analytical framework of tobacco taxation in China [14] and develop it fur-
ther in simulating and comparing two key policies: (1) a large increase in excise taxes, raising the share 
of all applicable taxes of the retail price of tobacco products to 75%; and (2) an implementation of total 
smoking bans in workplaces. Taxes currently only contribute to about 56% (39% for excise taxes) of re-
tail prices of cigarettes in China [4], which is far from the 70% excise tax contribution to the final con-
sumer price recommended by WHO to have a large impact on cigarette consumption [1,25]. On the 
other hand, worksite total bans represent an essential step forward on the way to comprehensive smoke–
free environments, which have been weakly enforced in China so far [20,26].
This paper builds on a former ECEA of tobacco taxation in China [14], and extends it in three important 
ways. First, it uses an updated set of parameters (eg, price of cigarettes, tax share as a percentage of ciga-
rette price; Table 1). Second, it estimates smoking–related premature deaths, and cases of impoverish-
ment and catastrophic expenditures due to OOP treatment costs of tobacco–related diseases, both critical 
measures of lack of financial protection commonly used by policymakers [48]. Third, it adds the exami-
nation of another key policy among the MPOWER measures [2], the enactment of smoking bans in work-
places.
We selected the policies of increases in excise taxes (i) and smoke–free workplaces (ii) as they were two 
essential MPOWER measures [2]. Policy (i) was chosen because China recently passed in 2015 a tobacco 
tax reform increasing the retail price of tobacco with tax then representing 56% of cigarette prices [4]; 
yet, this is far from WHO’s 70% recommendation [1,25]. Policy (ii) was chosen because of China’s recent 
advancements in adopting smoke–free laws. Notably, Beijing adopted in 2015 a comprehensive 100% 
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smoke–free law for all indoor public places with high compliance rates [22,49]. More than 15 other cit-
ies since enacted similar legislations or enforced smoke–free policies, such as Shanghai and Shenzhen in 
2017; nevertheless, such regulations are not always fully enforced, and China has yet to implement a na-
tionwide smoke–free legislation. Our choice of policies highlights the potentially large benefits to be reaped 
as China makes nascent but important, concrete steps towards reducing its own burden and, in turn im-
pacts the global burden of smoking.
Study population
We examined the current Chinese male population [27] as a whole (excluding Hong Kong and Macao 
Special Administrative Regions). Policy impact was estimated for males only, as they disproportionately 
engage in smoking [28,50]: nationwide, about 53% of males smoke compared to only 2% of females at 
ages 15 years and above [28]. The population was structured using five–year age groups from age 0 to 
age 84 and a single age group for all men above age 85; and further divided into income quintiles.
National smoking prevalence of manufactured cigarettes by age group was obtained from the Global Adult 
Tobacco Survey (GATS) China Report 2010 for ages 15–69 [28] (Table 1). A study of smoking among 
elderly in Hong Kong was used to estimate the smoking prevalence in men above age 70 [29]. The future 
smoking prevalence of those under age 15 was assumed to be the prevalence among 15– to 19–year–olds; 
and no additional smoking initiation would take place among those above age 15. These were two con-
servative assumptions as the prevalence among those aged older (eg, 25– to 49–year–olds) was higher 
(Table 1).
Price elasticity of demand for cigarettes varied per income quintile. We assumed an average price elastic-
ity of –0.38 [51], with greater elasticity among poorer smokers. We also assumed that price elasticity was 
twice as large in younger smokers (15– to 24–year–olds), who are more responsive to changes in prices 
(two–three times more) than older smokers [11,25]. Thus, we assigned 15– to 24–year–olds a 2–fold 
elasticity modifier across all quintiles, which we also applied to the elasticity that would affect smoking 
initiation for current 0–to 14–year–olds. Half of all price elasticity was apportioned to participation and 
half to consumption [11,25].
Policy scenarios
The two policies, excise tax increase and workplace total bans, were independently modeled and applied 
uniformly nationwide.
Excise tax increase
Excise taxes currently only contribute to about 39% of retail prices of cigarettes in China [4]. An excise 
tax hike passed fully onto the consumer and resulting in a 75% increase of the cigarette pack retail price 
was projected, which affected smoking participation, consumption, and initiation. This led to a 75% rate 
of all applicable taxes (a 65% excise tax rate) on the retail price. All changes in smoking behavior except 
initiation were modeled as occurring in the first year of the increase. The proportion of smokers quitting 
and “averted” future smokers (ie, current 0– to 14–year–olds that would not initiate smoking) was cal-
culated for each income quintile as the product of: the quintile–specific price elasticity, the proportion of 
the price elasticity affecting participation (one half), the youth modifier if appropriate, and the relative 
price increase. This proportion was further multiplied by the number of baseline smokers per age group 
to obtain the number of smokers who would quit or be averted.
Workplace total bans
The reduction in smoking following a total workplace ban was modeled as a one–time reduction in the 
number of baseline smokers based on a relative reduction in smoking prevalence of 9% (as used in 
SimSmoke China) [30]. We calculated the numbers of current smokers projected to quit and of future 
smokers averted by multiplying the number of baseline smokers per age group and the assumed relative 
reduction in prevalence.
Policy outcomes
Impact was assessed for: averted premature deaths; additional revenues generated through excise tax hike; 
averted OOP expenditures due to tobacco–related disease treatment costs; prevented cases of medical 
impoverishment (hereafter referred as poverty cases); and prevented cases of catastrophic expenditures. 
Benefits of tobacco tax and smoke-free workplaces in China
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Table 1. Inputs used in the modeling of the expansion of tobacco control policies in China.
Input Value Source
Male population by age group • 0–4 y–olds: 46 223 844
• 5–9 y–olds: 42 116 819
• 10–14 y–olds: 44 333 255
• 15–19 y–olds: 57 372 413
• 20–24 y–olds: 69 787 588
• 25–29 y–olds: 54 148 396
• 30–34 y–olds: 48 300 078
• 35–39 y–olds: 60 477 911
• 40–44 y–olds: 62 353 282
• 45–49 y–olds: 52 513 698
• 50–54 y–olds: 41 888 301
• 55–59 y–olds: 41 743 573
• 60–64 y–olds: 28 223 579
• 65–69 y–olds: 19 966 448
• 70–74 y–olds: 15 697 892
• 75–79 y–olds: 10 754 066
• 80–84 y–olds: 5 524 515
• 85 y–olds: 2 757 397
[27]
Smoking prevalence per age group  
(% of male population)
• 15–19 y–olds: 14.0%
• 20–24 y–olds: 48.8%
• 25–29 y–olds: 53.0%
• 30–34 y–olds: 52.2%
• 35–39 y–olds: 57.5%
• 40–44 y–olds: 68.0%
• 45–49 y–olds: 66.7%
• 50–54 y–olds: 58.0%
• 55–59 y–olds: 57.7%
• 60–64 y–olds: 47.3%
• 65–69 y–olds: 37.6%
• 70–74 y–olds: 21.0%
• 75–79 y–olds: 19.0%
• 80–84 y–olds: 17.0%
• 85 y–olds: 13.0%
Authors’ calculations based on 
[28,29]
Relative smoking prevalence per income 
quintile
•  Income quintiles I to IV: 1.14 times 
average per age group
•  Income quintile V: 0.86 times average per 
age group
[14,28]
Cigarette consumption (cigarettes per day) 
per income quintile
•  Income quintile I to V:  
{15.6, 15.5, 13.8, 12.7, 12.7}
[14,28]
Price per pack (20 cigarettes) (2015 US$) • US$ 2.00 (before excise tax increase)
• US$ 3.50 (after excise tax increase)
[4]
Taxes per pack (20 cigarettes) (2015 US$) • US$ 1.12 (before: 56% of retail price)
• US$ 2.63 (after: 75% of retail price)
[4]
Relative smoking prevalence reduction among 
workers after workplace smoking ban
• 9% [30]
Proportion of deaths among smokers 
attributable to smoking
• 0.50 [31]
Reduction of smoking–attributable death risk 
by age at quitting
• 15–19 y–olds: 96.9%
• 20–24 y–olds: 94.8%
• 25–29 y–olds: 92.1%
• 30–34 y–olds: 89.2%
• 35–39 y–olds: 86.6%
• 40–44 y–olds: 83.7%
• 45–49 y–olds: 79.5%
• 50–54 y–olds: 72.9%
• 55–59 y–olds: 62.8%
• 60–64 y–olds: 49.9%
• 65–69 y–olds: 36.4%
• 70–74 y–olds: 24.7%
• 75–79 y–olds: 15.7%
• 80–84 y–olds: 9.1%
• 85 y–olds: 4.5%
Authors’ derivations based on 
[31] (Online Supplementary 
Document, section 1)
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Table 1. Continued
Additional tax revenues were based on changes in smoking prevalence, consumption, and tax increase. 
Averted premature deaths among quitters were the primary health outcome. These averted deaths were 
then used to calculate the number of cases of poverty and catastrophic expenditures averted. All outcomes 
were examined by income quintile.
Tax revenues prior to policy change were calculated based on the average number of cigarettes consumed 
per day, the price per pack, the current tax rate (56%), and the baseline number of current smokers. Af-
ter policy change, revenues were based on non–quitting smokers, reductions in consumption, and tax 
increases through excise tax hike (from 56% to 75% of retail price).
Smoking–related premature deaths were calculated for all male smokers currently alive. We assumed that 
half of all deaths among smokers were attributable to smoking [31] and that the risk of death was atten-
uated among former smokers based on age at quitting. Under the simplifying assumption that no current 
smokers would quit in the absence of policy, we calculated the number of premature deaths without pol-
icy as half (ie, 50% premature mortality rate) [31] of the baseline smoker population and of those cur-
rently under age 15 anticipated to initiate smoking. The attenuation of excess mortality risk among for-
mer smokers was modeled by age at cessation using cubic splines based on age–specific risk reductions 
[31]. After policy, premature deaths were calculated as 50% of continuing smokers and the age–attenu-
ated reduction of baseline smokers quitting (Table 1). Averted premature deaths were apportioned among 
the four main causes of smoking–related death [32]: stroke, heart disease, neoplasms, and chronic ob-
structive pulmonary disease. Healthcare utilization for each cause and an adjustment per quintile were 
used to determine how many of those with an averted death would have incurred medical expenses. OOP 
expenditures were calculated by subtracting average inpatient reimbursement covered by insurance [45] 
from cause–specific treatment costs (see Section 1 in Online Supplementary Document).
Per capita income [46] and Gini coefficient [47] were used to create gamma distributions for income 
[52,53]. Simulations generated income for each averted premature death that would have incurred med-
ical expenses, at the quintile level. Averted cases of poverty were calculated as individuals for whom the 
simulated income was above US$ 1.90 per day but whose annual net income would have decreased to 
Benefits of tobacco tax and smoke-free workplaces in China
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Input Value Source
Proportion of smoking–attributable deaths per 
cause of death
• COPD: 11.3%
• Stroke: 45.5%
• Heart disease: 22.8%
• Neoplasm: 20.4%
[32]
Tobacco–related disease treatment costs (2015 
US$)
• COPD: US$ 2256
• Stroke: US$ 2197
• Heart disease: US$ 11 774
• Neoplasm: US$ 14 794
[14] and based on [33-40]
Utilization of health care by tobacco–related 
disease (%)
• COPD: 33%
• Stroke: 80%
• Heart disease: 81%
• Neoplasm: 50%
[14] and based on [41-43]
Relative utilization of health care per income 
quintile
•  Income quintile I to V: (0.79, 0.98,  
1.00, 1.08, 1.15) times average  
(applies to % above)
[14] and based on [44]
Fraction of health care costs reimbursed by in-
surance schemes
• 48% Authors’ derivation based on 
[45] (Online Supplementary 
Document, section 1)
Annual income per capita (2015 US$) • Income quintile I: 0 to US$ 992
• Income quintile II: US$ 992 to 1870
• Income quintile III: US$ 1870 to 2973
• Income quintile IV: US$ 2973 to 4718
• Income quintile V:> US$ 4718
Income distribution based on 
average per capita income of 
US$ 3039 and Gini coefficient of 
0.43 [46,47]
Assumed price elasticity of demand for ciga-
rette by age group (25 y–olds; 15–24 y–olds; 
future smokers ie, under 15 y–olds) and in-
come quintile
• Income quintile I: –0.64; –1.28; –1.28
• Income quintile II: –0.51; –1.02; –1.02
• Income quintile III: –0.38; –0.76; –0.76
• Income quintile IV: –0.25; –0.50; –0.50
• Income quintile V: –0.12; –0.24; –0.24
COPD, chronic obstructive pulmonary disease, y – year, d – day
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less than US$ 1.90 per day after paying out of pocket for disease treatment. Averted cases of catastrophic 
expenditures were calculated as individuals for whom OOP tobacco–related disease treatment costs would 
have exceeded 10% of their simulated annual income.
Sensitivity analyses
A number of sensitivity analyses were conducted to test key scenarios and parameters (see Section 2 in 
Online Supplementary Document). First, for excise tax hike, the model was run with a flat price elastic-
ity across income quintiles (eg, –0.38). Second, we tested the impact of “brand switching” by incorporat-
ing a parameter which could capture the proportion of smokers (proportions of 0.33 and 0.75 were tested) 
who would respond to tobacco price increases by switching to a cheaper cigarette brand instead of quit-
ting or decreasing consumption. This “brand switching” effect could capture for instance substitution to 
off–market (black market) products. Third, for workplace bans, we used an alternative effect size in assum-
ing both an absolute reduction in smoking prevalence of 3.8% and a decrease in consumption of 3.1 ciga-
rettes per day among continuing smokers based on a meta–analysis from four countries [17]. In this case, 
the absolute reduction in prevalence was further adjusted to 2.2% accounting for the proportion of work-
sites already having full bans (31%) [28] and restricting impact to men under age 60 that were employed 
(82%) [54]. Insufficient evidence however prevented from testing the differential responsiveness to work-
site bans by income quintile or by age group. Yet, we tested an alternative relative prevalence reduction of 
4.5% among the bottom income quintile (keeping 9% in all the other quintiles), to capture the possibility 
that smokers in the bottom quintile may not be employed in the formal sector where such smoking bans 
could be implemented. Fourth, for each policy, we selected two alternative poverty thresholds, US$ 1 and 
US$ 3 per day, respectively, to estimate the number of poverty cases averted.
Complete details of the mathematical derivations used and of the sensitivity analyses implemented 
are given in Online Supplementary Document. All simulations used the R statistical software 
(http:www.r–project.org).
RESULTS
Increasing the retail price of cigarettes by 75% (or raising the tax share as a proportion of the retail price 
for all applicable taxes from 56% to 75%) would reduce the number of tobacco–related premature deaths 
by 24 million: 61% of averted deaths would be among the bottom two income quintiles, compared to 
18% among the top two quintiles (Figure 1). This distribution is a consequence of poorer individuals 
being more responsive to the significant relative change (75%) in cigarette prices, and thus quitting in 
larger numbers. Additional annual tax revenues raised through excise tax hike would be US$ 47 billion: 
17% and 60% of these additional revenues would come from smokers from the bottom 40% and top 40% 
of the population income distribution, respectively (Figure 2). These findings are largely driven by poor-
er individuals being more responsive to the relative change in cigarette prices, hence quitting and smok-
ing less cigarettes in larger numbers. The lower smoking prevalence among the top income quintile ex-
plains the slight difference in revenues between quintiles IV and V (Figure 
2). OOP expenditures averted would be US$ 55 billion: 57% and 21% of 
these would be among smokers from the bottom 40% and top 40% of the 
income distribution, respectively (Figure 3). Nine million cases of poverty 
would be prevented, primarily among the bottom two quintiles (69%; Fig-
ure 4); and 16 million cases of catastrophic expenditures would be prevent-
ed, primarily among the bottom two quintiles (57%; Figure 5). This is a 
consequence of: poorer individuals being more responsive to the relative 
change in cigarette prices, quitting in larger numbers and facing less tobac-
co–related disease OOP treatment costs; a lower income of poorer individ-
uals; and the choice of the poverty threshold (see variations in the poverty 
cases findings when distinct poverty thresholds are used; Figure S3 in On-
line Supplementary Document).
Comparatively, implementing workplace bans would yield smaller reduc-
tions in tobacco–related premature mortality and poverty cases averted (Fig-
ures 1 and 4). This is due to the smaller effect size (eg, among adults, 9% 
relative reduction in smoking prevalence for workplace bans compared with 
an estimated average reduction of 0.40 by 0.75 by 1/2 ~ 15% for price hike). 
Figure 1. Impact of tobacco control policies (75% 
increase in the retail price of cigarettes through 
excise tax; workplace total smoking bans) in 
China, per income quintile, on the number of 
tobacco–related premature deaths averted.
Verguet et al.
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By implementing a ban, premature deaths were estimated to decrease by 12 
million and to be evenly distributed across quintiles, due to a more or less 
flat distribution of smoking prevalence and assumed equal responsiveness 
to smoking bans by income quintile. Four million cases of poverty would 
be prevented, primarily among the bottom two quintiles (52%), explained 
by the fact that poorer individuals had lower income. Compared with the 
excise tax increase, a reduction in smoking with workplace bans would de-
crease tax revenues by US$ 7 billion (Figure 2) and will not be compensat-
ed by tax hike on tobacco products. Larger decreases (47% of the total de-
crease) would be observed among the bottom two income quintiles as a 
result of a larger number of cigarettes consumed among these groups in the 
first place.
Sensitivity analyses showed that policy impact was affected by a number of 
parameters and scenarios. First, the distributional analysis of the excise tax 
was largely influenced by the differential responsiveness to price changes 
per income quintile. Predictably, the excise tax hike progressiveness disap-
peared when all quintiles were given the same price elasticity (Figure S1 in 
Online Supplementary Document). Assuming a flat price elasticity would 
equalize the number of premature deaths averted, lead to a larger share of 
additional taxes borne by the poor, while some pro–poor aspect of the im-
poverishment averted would be maintained as the poorer income quintiles 
would evidently still have a lower income. Second, cigarette brand switch-
ing could significantly alter the findings (Figure 6). Introducing brand 
switching produced large reductions in averted deaths (compared with the 
base case) equivalent to the proportion of individuals switching brands (eg, 
assuming 75% of smokers switch, deaths averted would decrease by 75%). 
Additional tax revenues through excise tax hike could increase substantial-
ly and were more evenly distributed among income quintiles, minimizing 
policy progressiveness. In summary, less progressiveness followed greater 
switching. Third, using an alternative effect size for workplace bans (abso-
lute reduction in smoking prevalence and cigarette consumption) would 
alter the conclusions (Figure S2 in Online Supplementary Document): 
both premature deaths and poverty cases averted would decrease; and the 
additional tax revenues would decrease further when smoking prevalence 
reduction is accompanied by consumption reduction. Likewise, a smaller 
prevalence reduction of 4.5% among the bottom quintile would decrease 
Figure 2. Impact of tobacco control policies (75% 
increase in the retail price of cigarettes through 
excise tax; workplace total smoking bans) in 
China, per income quintile, on the net change in 
annual tax revenues collected on cigarette sales 
among current smokers (15 years of age and 
above).
Figure 3. Impact of tobacco control policies 
(75% increase in the retail price of cigarettes 
through excise tax; workplace total smoking 
bans) in China, per income quintile, on the 
amount of out–of–pocket tobacco–related 
disease treatment costs averted.
Figure 4. Impact of tobacco control policies (75% 
increase in the retail price of cigarettes through excise 
tax; workplace total smoking bans) in China, per 
income quintile, on the number of tobacco–related 
poverty cases averted due to the prevention of out–
of–pocket tobacco–related disease treatment costs.
Figure 5. Impact of tobacco control policies (75% increase in 
the retail price of cigarettes through excise tax; workplace total 
smoking bans) in China, per income quintile, on the number 
of tobacco–related cases of catastrophic expenditures averted 
due to the prevention of out–of–pocket tobacco–related 
disease treatment costs.
Benefits of tobacco tax and smoke-free workplaces in China
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substantially (by 50%) the premature deaths averted, increase the OOP expenditures and the poverty and 
catastrophic cases among the poor; it would however decrease the revenue losses among the bottom in-
come quintile (Figure S2 in Online Supplementary Document). Fourth, we found that the poverty cas-
es headcounts could be substantially affected when using distinct poverty thresholds (Figure S3 in Online 
Supplementary Document). Expectedly, progressiveness was enhanced when the poverty threshold was 
reduced (eg, from US$ 3.00 to US$ 1.00 per day).
Figure 6. Impact of a 75% increase in the retail price of cigarettes through excise tax (proportion of smokers switching 
to cheaper cigarette brands, ie, “switchers”, was set at either 0%, 33%, or 75%) in China, per income quintile, on: the 
number of tobacco–related premature deaths averted (a); the net change in annual tax revenues collected on cigarette 
sales among current smokers (15 years of age and above) (b); the amount of out–of–pocket tobacco–related disease 
treatment costs averted (c); the number of tobacco–related poverty cases averted due to the prevention of out–of–
pocket tobacco–related disease treatment costs (d); and the number of tobacco–related cases of catastrophic expendi-
tures averted due to the prevention of out–of–pocket tobacco–related disease treatment costs (e).
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DISCUSSION
We studied the distributional impact of expanding two tobacco control policies, aggressive increase in the 
excise tax on tobacco products and enforcement of workplace smoking bans, in China. On the one hand, 
excise tax hike passed onto the consumer in the form of a 75% retail price increase would prevent 24 
million premature deaths (about 2% of China’s population) and 9 million cases of poverty, and yield an 
annual US$ 47 billion more in revenues. China’s poorest would experience the greatest benefits in avert-
ed deaths and impoverishments while bearing a smaller burden of the tax hike. On the other hand, in-
stituting workplace smoking bans would have a more moderate impact on mortality and impoverishment 
averted. Assuming a relative decrease in smoking prevalence of 9%, 12 million premature deaths (or 1% 
of the Chinese population) and 4 million poverty cases could be averted, while revenues would decrease.
This analysis has shown that expanded tobacco control could promote equity at the national level in Chi-
na. Yet, a subnational examination of smoking–related inequalities is required to fine tune policy. Signif-
icant geographical variations in income and health exist in China, with the West and Southwest less eco-
nomically advanced, uneven access to health care between urban and rural populations, and considerable 
intra–urban inequality. Even in the major cities like Beijing, large health and economic gains can accrue 
for the poor.
Our estimates of averted premature mortality and revenue gains are consistent with previous work [13,14]. 
Few models on impact of workplace smoking bans exist against which to compare our results. We chose 
to focus on workplace bans given availability of data and also because the working population of ages 
25–54 has the highest smoking prevalence and thus is of greater relevance [28]. Unfortunately, the lack 
of clear evidence [18] for differential responses to smoke–free policies across socio–economic groups pre-
cluded us from examining whether such policies could redress inequities observed in outcomes.
Nevertheless, our analysis presents a number of limitations. First, our estimates are sensitive to assump-
tions about the price elasticity of demand for tobacco. We have used an elasticity of –0.38 following norms 
from developed countries [11]. China has a few studies estimating price elasticity of demand for tobacco 
with ranges from –0.84 to –0.01 [51]. Nonetheless, we elected to use a value closer to high–income coun-
tries to get a more conservative estimate as these studies report a wide range of price elasticities. Second, 
our effect size for the relative reduction in prevalence due to smoking bans (eg, 9%) is limited by basing 
it on simulation inputs [30] that may not be generalizable. We certainly underestimated the potential im-
pact of bans by our focus on mortality and men alone. Women could be the main beneficiaries of reduced 
SHS exposure [55,56], which could also lead to significant decreases in hospital admissions and associ-
ated OOP medical payments [57]. In addition, the distributional impact of smoke–free policies is unclear. 
In four countries, there was no correlation between socio–economic status and the introduction of smok-
ing bans in workplaces [58]; and Dinno and Glantz [59] found that the decrease in smoking prevalence 
due to clean air laws in the US did not vary by socio–economic status. Third, in the past, tax increases 
have not generated significant behavior changes among Chinese smokers [51], which may make our 
model appear optimistic. For example, cigarette prices have not increased in China at the same rate as 
disposable incomes making them more affordable [51]. However, past excise tax increases have been low, 
and we emphasize here the importance of large excise tax hikes. Furthermore, cigarettes in China also 
have wide variation in prices, allowing consumers to switch to lower–priced brands when taxes increase 
[60-63]. Therefore, we have modeled different levels of brand–switching in sensitivity analyses to explore 
its potential impact on our estimates (Figure 4). This is equivalent to using a lower average price elastic-
ity, similar to those seen in other models [13,30]. With the largest brand–switching modeled (equivalent 
to an average elasticity of –0.10), five million premature deaths would still be averted, but policy progres-
sivity would be diminished. A more moderate switching parameter (corresponding to an average elastic-
ity of –0.25) would project an averted 14 million premature deaths and preserve some progressivity. How-
ever, more research is needed for quantifying the extent of brand–switching and which smokers are more 
likely to switch to enact an optimum level of taxation. Fourth, since we examined the consumer perspec-
tive, one major limitation is not taking into account the role of the Chinese State Tobacco Monopoly Ad-
ministration (STMA) and China’s tobacco tax structure. STMA determines cigarette prices, including the 
use of central government and local government taxes, and thus, tax increases do not get necessarily 
passed onto the retail price of tobacco products [63,64]. Excise taxes will only have an effect when in-
creases are passed onto the consumers through higher retail prices [60,63], which is what our analysis 
assumed. If the tax increase were not fully (but partially) passed onto the consumers, we would still ob-
serve reductions (though diminished) in premature mortality and tobacco–related OOP spending and 
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impoverishment. Fifth, as in all models, we had to balance interpretability and strength of existing evi-
dence with realism. For example, we assumed that changes in smoking behaviors due to policy would 
occur among individuals who would otherwise not have quit on their own. Thus, we did not attempt to 
capture background quitting or consumption reductions. This simplifying assumption would have re-
sulted in an overestimate of impact in presence of downward smoking trends. We also assumed that all 
changes in smoking behaviors were instantaneous and persisted over the life of individuals; and did not 
account for the fact that increased taxes may themselves be a source of impoverishment and enhance pov-
erty, notably for those among the bottom income quintile who do no quit. Finally, for simplicity, our anal-
ysis studied one policy at a time, and thus did not model any synergies and interactions from the effects 
of both policies. We expect that as tobacco control in China grows and individual policies become inte-
grated in coordinated national frameworks, evidence may be collected and research be conducted to ex-
amine complementarity of measures and their results.
Our analysis focuses on China but its findings are relevant to many other low– and middle–income coun-
tries. Other settings have already successfully implemented excise tax hikes and smoking ban policies 
validating our approach. Large increases in specific excise taxes can have a substantial impact on cigarette 
consumption [11,12,25]. For example, youth smoking is very responsive to cigarette prices as shown by 
data from 17 low– and middle–income countries [65]; and over 15 years, South Africa tripled cigarette 
prices and halved tobacco consumption with large tax hikes [66,67]. Likewise, a review [18] showed a 
consistent positive impact of national smoking bans on improving cardiovascular health outcomes and 
reducing mortality and morbidity from tobacco–related diseases, based on data from 21 countries includ-
ing the middle–income countries of Argentina [68,69], Uruguay [70], Panama [71], and Turkey [72]. And 
a meta–analysis demonstrated that workplace bans in Australia, Canada, Germany, and the U.S led to a 
4% absolute reduction in smoking prevalence [17].
Our results highlight the need to consider not only the overall impact of policies to decrease smoking but 
also how impact is distributed across sub–populations. More importantly, the distributional impact of to-
bacco control efforts provides governments with relevant evidence to make the biggest difference for the 
populations that most need it. We show here that increasing cigarette taxes and instituting smoke–free 
workplaces can potentially prevent millions from being impoverished as a consequence of smoking–re-
lated medical expenditures. Because of the structure of the existing tobacco policies and state–owned to-
bacco industry, we believe that a priority should be placed on full implementation of all MPOWER mea-
sures [2] including comprehensive smoking bans and large excise tax hikes. Following India’s 
differentially taxed cigarettes based on the length of cigarettes may help mitigate brand–switching and 
other compensating behaviors [73]. Higher taxes and workplace smoking bans can work well together 
and are complimentary: by having a mutually strengthening effect (eg, smoking bans impose social norms 
and enhance the price effect of taxes) they can reinforce each other to both lower consumption and bring 
large health and economic benefits to households. In addition, higher taxes can lead to revenue increas-
es partially offsetting revenue losses from smoking bans. Such benefits would arise from large excise tax 
hikes that explicitly narrow the price differentials from top to bottom cost cigarettes, combined with total 
(not partial) smoking bans. In summary, the simultaneous implementation of both policies would pres-
ent great synergies: mutual strengthening and exponentiation of the health and financial protection ben-
efits (eg, poverty cases averted); compensation of lost revenues by smoke–free places by increases in ex-
cise taxes; and providing a resulting combined pro–poor policy where the potentially flat distribution of 
benefits of smoke–free places are compensated by increases in excise taxes, and increases in taxes to the 
poor are compensated by reductions in cigarette spending due to bans.
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